Mediterranean Diet and atherothrombosis biomarkers: a randomized controlled trial

Mediterranean Diet and atherothrombosis biomarkers: a randomized controlled trial

Scope. To assess whether following a Mediterranean diet (MedDiet) improved atherothrombosis biomarkers in high cardiovascular risk individuals. Methods and results. In 358 random volunteers from the PREvención con DIeta MEDiterránea trial, we assessed the 1-year effects on atherothrombosis markers...

Full description

Bibliographic Details
Main Authors: Hernáez, Á. (Álvaro), Castañer, O. (Olga), Tresserra-Rimbau, A. (Anna), Pinto, X. (Xavier), Fito, M. (Montserrat), Casas, R. (Rosa), Martinez-Gonzalez, M.A. (Miguel Ángel), Corella, D. (Dolores), Salas-Salvado, J. (Jordi), Lapetra, J. (José), Gomez-Gracia, E. (Enrique), Aros, F. (Fernando), Fiol, M. (Miquel), Serra-Majem, L. (Luis), Ros, E. (Emilio), Estruch, R. (Ramón)
Format: info:eu-repo/semantics/article
Language:eng
Published: John Wiley & Sons 2022
Subjects:
Atherothrombosis
Biomarkers
Cardiovascular risks
Clinical trials
Mediterranean diet
Online Access:https://hdl.handle.net/10171/64436

Internet

https://hdl.handle.net/10171/64436

Similar Items